NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 882.50
+4.75 (0.54%)
At close: Aug 21, 2026
NATCO Pharma Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, NATCO Pharma stock has a consensus rating of "Hold" and an average price target of ₹1,004. The average 1-year stock price forecast is 13.82% higher than the current stock price, while the lowest is ₹712.00 (-19.32%) and the highest is ₹1,180 (+33.71%).
Price Target: ₹1,004 (+13.82%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for NATCO Pharma stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Financial Forecast
Revenue This Year
32.33B
from 40.78B
Decreased by -20.74%
Revenue Next Year
35.89B
from 32.33B
Increased by 11.04%
EPS This Year
42.29
from 79.20
Decreased by -46.61%
EPS Next Year
47.37
from 42.29
Increased by 12.02%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.